Phone: +32 4 3614232
Fax: +32 4 3670063

http://www.zentech.be

info@zentech.be
ZenTech S.A. Company Figures
Number of employees: 20-49
Sales volume: 1-9 Mio US $
Export content: > 75%
Year of foundation: 2001
Area of business:
■Diagnostics

ZenTech S.A. Company Profile
About us

With headquarters in the Liège Science Park in Belgium, Zentech is a biotechnology company highly specialized in the development, production and marketing of in vitro medical diagnostic tests in the field of all immune and chronic disorders. Our innovative and effective diagnostic kits allow the detection and the quantification of the biomarkers involved in the diseases of the immune system (autoimmune diseases, allergy, food intolerance), in diabetes screening and in ageing (tissue degeneration, oxidative stress).
For each of these pathologies, Zentech has developed a line of specific products meeting expectations and needs of the market, becoming thus one of the major actors of the sector.

EXPERTISE AND INNOVATION

Zentech is heavily involved and has considerable expertise in the research, development, manufacture and marketing of in vitro medical diagnostic tests.
This know-how together with close links with leading European medical and university research centres, enables the development by Zentech of innovative and effective products with high quality standards for both established and developing market segments.Company Profile
About us

With headquarters in the Liège Science Park in Belgium, Zentech is a biotechnology company highly specialized in the development, production and marketing of in vitro medical diagnostic tests in the field of all immune and chronic disorders. Our innovative and effective diagnostic kits allow the detection and the quantification of the biomarkers involved in the diseases of the immune system (autoimmune diseases, allergy, food intolerance), in diabetes screening and in ageing (tissue degeneration, oxidative stress).
For each of these pathologies, Zentech has developed a line of specific products meeting expectations and needs of the market, becoming thus one of the major actors of the sector.

ZenTech S.A. Product Categories
Allergies
Auto-immune diseases
Units and systems for hormone determination
Diagnostic agents/kits for hormone determination
Thyroid function hormones
Diagnostic agents / kits for thyroid gland, etc. determination
Immuno assay systems
Enzyme immunoassay (EIA, ELISA, EMIT)
Heterogenous enzyme immunoassay (ELISA)
Homogenous enzyme immunoassay
Immunoblots / dotblots
Immunoradiometric assay (IRMA)
Radioimmunoassay (RIA)
Radioimmunoassay (RIA): competitive method (CPBA)
Radioreceptor assay
Specific organ function assays
Specific proteins
Rapid tests – Immunochemistry
Infectious desease tests
Rapid tests – Microbiology
Rapid tests – Infectious immunology

ZenTech S.A. Product Information of Product Category
Auto-immune diseases

Prenatal screening
SCREENING 1ST TRIMESTER
Down’s Syndrome screening during the first trimester of pregnancy

Maternal Serum screening
The mother’s blood is checked for a combination of 2 normal first trimester proteins : Free-ß subunit of the human chorionic gonadotropin (Free ß-hCG*) and pregnancy associated plasma protein-A (PAPP-A) make up the standard tests. These tests are independent measurements, and when taken along with the maternal age, can calculate the risk of having a baby with Down’s Syndrome and other chromosomal abnormalities.

The 2 immunoassays for the quantitative determination of PAPP-A and Free ß-hCG * in maternal serum are sandwich enzyme immunoassays supplied as separate kits of 96 tests. The procedure of the both assays is standardized so that they can be easily performed simultaneously.

*The Free-ßhCG kit has not received CE mark for Down’s syndrome screening. This assay is not available for Down’s Syndrome screening in the following countries: Austria, Belgium, Switzerland, Germany, Denmark, Spain, France, The United Kingdom, Italy, Liechtenstein, Luxemburg, The Netherlands, Sweden, Japan, Australia and the United States of America.

ZenTech S.A. Company Contacts
Department/ Name Contact / e-Mail
Chief Executive Officier/Jean-Claude HAVAUX jc.havaux@zentech.be

Phone: +32 4 36409-10
Fax: +32 4 36409-19

http://www.cryomorpho.com

info@cryomorpho.com

Wellcare Products S.A. Company Figures
Number of employees: 1-19
Sales volume: < 1 Mio US $
Export content: max. 50%
Year of foundation: 2004
Area of business:
■ Physiotherapy / Orthopaedic Technology / Occupational Therapy
■ Commodities and Consumer Goods for Surgeries and Hospitals

Wellcare Products S.A. Company Contacts
Department/ Name
Patricia Fuselli – Business Relationship Manager

Contact / e-Mail
Phone : +32 (0)4 364 09 10; Mobile : +32(0)475 311 463, Skype : patricia.fuselli
patricia.fuselli@cryomorpho.com

Wellcare Products S.A. Company Profile
Cryo MORPHO™ Compress – Wellcare Products SA
Wellcare Products S.A. is focussed on the relief and prevention of pain, by promoting, marketing and distributing the multiple applications of a World patent, the FFleXX Cryo/Thermotherapy Compress . This is a unique compress, wearable in movement and with constant temperature (materials with phase change), This Compress is approved by a large majority of the medical world and finalized by its Research and Development department together with the University of Liège.
Wellcare Products is launching the Cryo MORPHO™ Compress worldwide, and is looking for Distribution and Integration Partners.

Cryo MORPHO™ Compress covers a very wide spectrum of applications in the medical field :

- Traumatology
- Osteoarthrosis
- Orthopaedics
- Rheumatology
- Neurology
- Emergencies
- Cosmetic surgery
- Dermatology …

MORPHO™ structure is characterised by:

- Choice of thermal shock
- Adaptable and long lasting constant temperature (materials with phase change)
- Continuous thermotherapy
- Long duration (autonomy)
- Static and dynamic thermotherapy
- Homogeneous contact on any kind of shape
- Mobility, perfect moulding of surfaces, even in movement and under pressure
- Easy and quick to put on leg, arm, shoulder, knee, etc…
- Safety : no toxic content
- Long life period.

Cryotherapy represents 80% of the current medical applications.

MORPHO™ is the only one who combines all the following effects :

- Superficial painkiller : superficial anaesthesia
- Analgesic : reduction of articular and muscular pain
- Anti-inflammatory : reduction of inflammation to its necessary level
- Vasomotor : limitation of bruises –oedemas
- Reduction of medicinal grips : analgesic, anti-inflammatory, soporific, …

Other high potential fields are surveyed with great attention, followed by new developments and the search for partnerships or co-developments.